You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CORGARD Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Corgard, and when can generic versions of Corgard launch?

Corgard is a drug marketed by Uswm and is included in one NDA.

The generic ingredient in CORGARD is nadolol. There are five drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the nadolol profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Corgard

A generic version of CORGARD was approved as nadolol by RISING on October 31st, 1993.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CORGARD?
  • What are the global sales for CORGARD?
  • What is Average Wholesale Price for CORGARD?
Summary for CORGARD
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 60
Clinical Trials: 2
Patent Applications: 4,544
Drug Prices: Drug price information for CORGARD
What excipients (inactive ingredients) are in CORGARD?CORGARD excipients list
DailyMed Link:CORGARD at DailyMed
Drug patent expirations by year for CORGARD
Drug Prices for CORGARD

See drug prices for CORGARD

Recent Clinical Trials for CORGARD

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
BioHealthonomics Inc.Phase 2
AgoneX Biopharmaceuticals, Inc.Phase 2
Baylor College of MedicinePhase 1/Phase 2

See all CORGARD clinical trials

US Patents and Regulatory Information for CORGARD

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Uswm CORGARD nadolol TABLET;ORAL 018063-005 Oct 28, 1986 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Uswm CORGARD nadolol TABLET;ORAL 018063-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Uswm CORGARD nadolol TABLET;ORAL 018063-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for CORGARD

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Uswm CORGARD nadolol TABLET;ORAL 018063-005 Oct 28, 1986 ⤷  Sign Up ⤷  Sign Up
Uswm CORGARD nadolol TABLET;ORAL 018063-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Uswm CORGARD nadolol TABLET;ORAL 018063-002 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.